Chongqing Zhifei Biological Products Co Ltd (300122):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Chongqing Zhifei Biological Products Co Ltd (300122) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8187
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chongqing Zhifei Biological Products Co Ltd (Zhifei) is a vaccine manufacturer. The company offers HibACon, MeningACon, menwayc, mycobacterium vaccae, haemophilus influenzae type b conjugate vaccine and hepatitis A (live) vaccine, freeze-dried. It research, develops, produces and markets vaccines. Zhifei’s products find application in the prevention of invasive meningococcal disease, including meningitis and pneumonia; epidemic cerebrospinal meningitis, Hepatitis A and influenza. The company’s reserch and development, manufacture and marketing units are located in Beijing economic-technological development area. The company markets its products in different parts of China. Zhifei is headquartered in Chongqing, China.

Chongqing Zhifei Biological Products Co Ltd (300122) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Chongqing Zhifei Biological Products Enters into Research Agreement with Institut Pasteur of Shanghai Chinese Academy of Sciences 10
Chongqing Zhifei Biological Enters into Agreement with BD China 11
Equity Offering 12
Chongqing Zhifei Biological Plans to Raise up to USD343 Million in Private Placement of Shares 12
Chongqing Zhifei Biological Products Co Ltd – Key Competitors 13
Chongqing Zhifei Biological Products Co Ltd – Key Employees 14
Chongqing Zhifei Biological Products Co Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chongqing Zhifei Biological Products Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chongqing Zhifei Biological Products Enters into Research Agreement with Institut Pasteur of Shanghai Chinese Academy of Sciences 10
Chongqing Zhifei Biological Enters into Agreement with BD China 11
Chongqing Zhifei Biological Plans to Raise up to USD343 Million in Private Placement of Shares 12
Chongqing Zhifei Biological Products Co Ltd, Key Competitors 13
Chongqing Zhifei Biological Products Co Ltd, Key Employees 14
Chongqing Zhifei Biological Products Co Ltd, Subsidiaries 15

List of Figures
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Chongqing Zhifei Biological Products Co Ltd (300122):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Verbundnetz Gas Aktiengesellschaft:石油・ガス:M&Aディール及び事業提携情報
    Summary Verbundnetz Gas AG (VNG), a subsidiary of EnBW Energie Baden-Wurttemberg AG, is a natural gas company that explores, produces, stores, trades and transports natural gas. The company has natural gas licenses on the Norwegian continental shelf and the Danish North Sea. VNG also offers gas stor …
  • China Petroleum & Chemical Corporation (600028)-石油・ガス分野:企業M&A・提携分析
    Summary China Petroleum & Chemical Corporation (Sinopec), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and producti …
  • Caprion Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Caprion Biosciences Inc (Caprion) is a provider of proteomics and immune monitoring services. The company’s proteomic based services include neo-epitope discovery and characterization, biomarker discovery, fit-for-purpose assays, host cell protein detection and PK assays, among others. It of …
  • Dentsply Sirona Inc (XRAY):医療機器:M&Aディール及び事業提携情報
    Summary Dentsply Sirona Inc (Dentsply Sirona) formerly Dentsply International Inc, is a medical device company that designs, develops, manufactures and markets a wide range of products for the dental market. It provides dental prosthetics, precious metal dental alloys, dental ceramics, endodontic in …
  • Panasonic Corporation (6752):企業の財務・戦略的SWOT分析
    Panasonic Corporation (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • TDK Corporation:企業の戦略・SWOT・財務情報
    TDK Corporation - Strategy, SWOT and Corporate Finance Report Summary TDK Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Saudi Pharmaceutical Industries & Medical Appliances Corp (2070):製薬・医療:M&Aディール及び事業提携情報
    Summary Saudi Pharmaceutical Industries & Medical Appliances Corp (SPIMACO) develops, manufactures, and sells pharmaceutical products and medical appliances. The company offers its products in anti-infectives, cardio-vascular, diabetes, GIT, iron supplement, men health, musculoskeletal, pschychatric …
  • Silmag SA:企業の製品パイプライン分析2018
    Summary Silmag SA (Silmag) is a manufacturer of biomedical products. The company offers products for vascular access, drainage, digestive tract, airway and urinary system. Its products include catheters, drainage tube, occlusion and identification tape, airway tube, double pigtail ureteral stent, cl …
  • WorleyParsons Ltd (WOR):電力:M&Aディール及び事業提携情報
    Summary WorleyParsons Ltd (WorleyParsons) is a provider of professional services. Its services cover the full lifecycle, from creating new assets to sustaining and enhancing operating assets. The company provides integrated solution for deepwater developments with the associated subsea, pipelines, r …
  • Taylor Corporation:企業の戦略・SWOT・財務情報
    Taylor Corporation - Strategy, SWOT and Corporate Finance Report Summary Taylor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • KAMCO Investment Company K.S.C.P. (KAMCO):企業の財務・戦略的SWOT分析
    KAMCO Investment Company K.S.C.P. (KAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • MicroStrategy Inc (MSTR):企業の財務・戦略的SWOT分析
    MicroStrategy Inc (MSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Roquette Freres SA:企業の戦略的SWOT分析
    Roquette Freres SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • PT Bakrieland Development Tbk:企業の戦略・SWOT・財務情報
    PT Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Esperite NV (ESP):企業の財務・戦略的SWOT分析
    Esperite NV (ESP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Lava Therapeutics BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Lava Therapeutics BV (Lava Therapeutics) is a biotechnology company which develops immune oncology biopharmaceuticals products. Its proprietary V?9Vd2 T-cell engager candidates bind to the conserved (monomorphic) T-cell receptor of V?9Vd2 T-cells which exhibit potent cytotoxicity, interferon …
  • Albireo Pharma Inc (ALBO)-製薬・医療分野:企業M&A・提携分析
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., is a specialty biopharmaceutical company that focuses on the development and commercialization of innovative bile acid modulators for the treatment of orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and d …
  • Fuller, Smith & Turner Plc:企業の戦略・SWOT・財務情報
    Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report Summary Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Biovotion AG:医療機器:M&Aディール及び事業提携情報
    Summary Biovotion AG (Biovotion) is a medical device company that offers healthcare monitoring solutions. The company offers Ecosystem, Everion and Augment app. Its Ecosystem is a wearable sensor monitor that consists of data collection, analytics, storage in the cloud and visualization tools used i …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆